- Home
- FTHY vs CRMD Comparison
FTHY vs CRMD Comparison
Compare FTHY & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHY | CRMD |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.4M | 626.0M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | FTHY | CRMD |
|---|---|---|
| Price | $13.51 | $8.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 102.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.98 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $13.20 | $6.13 |
| 52 Week High | $14.98 | $17.43 |
Technical Indicators
Market Signals| Indicator | FTHY | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.78 | 57.01 |
| Support Level | $13.25 | $8.09 |
| Resistance Level | $13.82 | $8.94 |
| Average True Range (ATR) | 0.16 | 0.30 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 42.26 | 48.74 |
Price Performance
Historical ComparisonAbout FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.